CytoDyn Files Pivotal Trial Protocol for HIV Monotherapy with FDA

World News: . []

VANCOUVER Washington May 15 2019 GLOBE NEWSWIRE -- LINK  Inc OTCQB CYDY a late stage biotechnology company developing leronlimab PRO 140 a CCR5 antagonist with the potential for LINK  therapeutic indications announced today tha t it ha...

More news and information about CytoDyn Inc.

Published By:

Globe Newswire: 13:20 GMT Wednesday 15th May 2019

Published: .

Search for other references to "cytodyn" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us